AEON Biopharma, Inc. Cash Flow Quality Index
AEON Biopharma, Inc. cash flow quality index. AEON Biopharma, Inc. (AEON) has a Cash Flow Quality Index of -0.87x as of March 2025. Operating cash flow of $-7.91 Million is below net income of $9.10 Million, suggesting accrual-heavy earnings not yet converted to cash. See AEON Biopharma, Inc. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of AEON Biopharma, Inc. (2019–2024)
Cash flow quality index of AEON Biopharma, Inc. from 2019 to 2024. Historical Cash Flow Quality Index for AEON Biopharma, Inc. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore AEON Biopharma, Inc. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
AEON Biopharma, Inc. Cash Flow Quality Index by Year (2019–2024)
AEON Biopharma, Inc. cash flow quality index by year from 2019 to 2024. Year-by-year earnings quality comparison for AEON Biopharma, Inc.. For the full cash flow conversion analysis, see cash flow conversion of AEON Biopharma, Inc..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.48x | $-20.29 Million | $42.01 Million | ▼ -73.2% |
| 2019 | -0.28x | $-44.73 Million | $160.31 Million | — |